Clinical trial
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients…
NCT00110123 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated
Key facts
| NCT number | NCT00110123 |
|---|---|
| Title | Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma |
| Official title | Intravenous Versus Intra-Arterial Fotemustine Chemotherapy in Patients With Liver Metastases From Uveal Melanoma: A Randomized Phase III Study of the EORTC Melanoma Group |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intraocular Melanoma, Metastatic Cancer |
| Intervention type | Drug |
| Interventions | fotemustine, isolated perfusion |
| Enrollment | 171 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2011 |
| First posted | May 4, 2005 |
| Last update posted | Sep 24, 2012 |
| Countries | Italy, Poland, Switzerland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: